Better Coronavirus Stock: Inovio vs. Sorrento Therapeutics
It's a great time to be a small biotech focused on fighting COVID-19. Inovio Pharmaceuticals (NASDAQ: INO) stock has skyrocketed more than 600% higher so far this year. Shares of Sorrento Therapeutics (NASDAQ: SRNE) have more than doubled.
Investors hoping to make tremendous profits from potential COVID-19 therapies and vaccines likely have both Inovio and Sorrento on their radar screens. But which of these coronavirus-focused biotechs is the better pick?
Image source: Getty Images.
Source Fool.com
